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The  proteomic  approach  allowed  identiﬁcation  of  several  proteins  altered  by AuNPs  exposure.
AuNPs  treatment  induces  ECM  disregulation.
Mitochondria  elongation  to preserve  cell  viability  during  the autophagic  response.
Proteomics  link  to system  biology  analysis  is a valuable  tool  to understand  and  predict  nanoparticles’  toxicity.
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a  b  s  t  r  a  c  t
Although  gold  nanoparticles  (AuNPs)  are  currently  used  in  several  industrial  products  and  biomedical
applications,  information  about  their  biological  effects  is  very  limited.  Thus,  it is becoming  crucial  to
assess  their  safety  and  adequately  investigate  the  complexity  of  cell–nanoparticles  interactions.  In  this
work,  the  Balb/3T3  mouse  ﬁbroblast  cell  line  was selected  as  an  in  vitro  model  to study  the  effects
of  AuNPs.  Alteration  of cellular  processes  and  biochemical  pathways  caused  by  AuNPs  exposure  was
investigated  by analysing  the  differentially  expressed  proteome.  Of  interest  was  the  difference  observed
in the  protein  pattern  expression  of cells  exposed  to AuNPs.  It was  found  that  88  and  83 proteins  were
de-regulated  after  exposure  to 5 and  15  nm  AuNPs,  respectively.  Analysis  of  the  proteome  revealed  that
AuNPs triggers  several  pathways  related  to  cellular  growth  and  proliferation,  cell  morphology,  cell cycle
regulation,  cellular  function  and  maintenance,  oxidative  stress,  and  inﬂammatory  response.  Moreover,
SPR analysis  showed  an  increase  of  ECM  proteins  biosynthesis  in  cells  exposed  to AuNPs.  We  observed  by
TEM analysis  that NPs  are  internalized  and  conﬁned  mainly  in  autophagosomes.  Endoplasmic  reticulum
stressed  and modiﬁcation  at mitochondrial  level  occurred.  This  study  aims  to  improve  existing  knowledgextracellular matrix (ECM)
necessary  for a  correct  assessment  of the  balance  between  AuNPs  potential  adverse  and beneﬁcial  effects
and  might  have  important  implications  for  biomedical  applications  (e.g.  nanomedicine).
To  conclude  proteomics  link  to system  biology  analysis  is a  valuable  tool to understand  and  predict
nanoparticles’  toxicity,  furthermore  it has  the potential  to  reveal  pathways  that may  not  be immediately
evident  with  classical  toxicological  assays.
rs.  Pu© 2014  The  Autho
. Introduction
In the last decades gold compounds had a widespread use in
he treatment of rheumatoid arthritis, cancer, AIDS and bronchial
sthma (Shaw, 1999; Muranaka et al., 1978). Gold complexes
ave been shown to be the material of choice in many diagnostic
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platforms and the down to the ‘nano-size’ has nowadays further
broadened the potential of gold in several ﬁelds of application
such as microelectronics (Seker and Demir, 2011), energy produc-
tion (Saunders, 2012), environmental remediation (Bootharaju and
Pradeep, 2012), material engineering (Peralta-Videa et al., 2011), as
well as in biomedicine (Kumar et al., 2011). Gold nanoparticles are
also widely used in consumer products such as cosmetics (Suang
et al., 2011).
The great stability of small gold colloidal particles (AuNPs)
together with their easy synthesis process and functionaliza-
tion offers, as mentioned above, great possibilities in the ﬁeld of
article under the CC BY-NC-ND license
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anomedicine (Thakor et al., 2011). In particular, AuNPs surface
odiﬁcations by selective immobilization of proteins, ligands or
ntibodies, make them suitable for targeting bio-distribution, phar-
aceutical therapy, or diagnostic imaging (Trickler et al., 2011).
ecently, Larguinho and Baptista (2012) have reported the great
nterest in AuNPs as promising agents for cancer chemotherapy.
Although the number of nano-gold based consumer products is
ncreasing, information about risk exposure and potential health
ffects are still very limited. AuNPs may  enter the human body in
ifferent ways, e.g. by inhalation, ingestion, skin contact or admin-
stered intravenously, be distributed in different organs, excreted
r/and can accumulate in the body.
Several studies have been published reporting the effects of
uNPs of different sizes and/or functionalization on different cell
ines (Tsai et al., 2012; Miranova et al., 2010), but still little is known
bout understanding which pathways and cellular mechanisms are
odiﬁed following AuNPs interactions with cells.
In the past decade, the high resolution achieved in proteins
eparation, as well as the progress made in the areas of mass
pectrometry (MS), in terms of sensitivity and speciﬁc protein iden-
iﬁcation, led to signiﬁcant developments in proteomic techniques,
aking it a powerful platform for toxicological studies. However,
o date, studies which employ proteomic techniques in the ﬁeld of
anomaterials are still limited (Lai et al., 2012).
In our previous work (Coradeghini et al., 2013) we investigated
he toxicity and uptake of 5 and 15 nm AuNPs on Balb/3T3 mouse
broblast. In this work, the proteomic approach was applied to
nvestigate the alteration of the proteome of the cytoplasmic com-
artment of Balb/3T3 cells caused by the AuNPs exposure. Data
roduced by MS  were interpreted using systems biology analysis
nd allow us to explore underlying cellular response mechanisms
o AuNPs exposure.
In addition, we performed some preliminary analysis of the
ifferentially phosphorylated proteins in response to 5 nm AuNPs
reatment using multiplexed staining and image analysis. We  then
nvestigated by surface plasma resonance (SPR) the dysregulation
f ECM proteins biosynthesis, assessing and quantifying the pro-
uction of collagen type I and ﬁbronectin in Balb/3T3 cells exposed
o AuNPs. To conclude, we analyzed by detailed transmission elec-
ron microscopy (TEM) the AuNPs uptake process reporting the
ate of the internalized NPs and their potential effects at organelles
evel.
It is known that omics data have the potential to reveal path-
ays that may  not be immediately evident by classical toxicological
tudies. Therefore, by applying a proteomic approach to explore
he cellular pathways altered by AuNPs exposure, this paper aims
o improve existing knowledge, necessary for a correct assess-
ent of AuNPs potential adverse effects and might have important
mplications for developing NPs for biomedical applications. To our
nowledge, this is among the ﬁrst studies reporting on the modiﬁ-
ation of the proteome pattern expression in cells exposed in vitro
o AuNPs and provides a deeper insight into how AuNPs interact
ith biological systems.
. Materials and methods
.1. Gold nanoparticles synthesis and characterization
AuNPs of 5 and 15 nm size were produced by NaBH4 (Sigma–Aldrich, St. Louis,
O,  USA) reduction of a starting solution of 2.5 mM sodium citrate (Sigma–Aldrich)
nd 0.5 mM HAuCl4 (Sigma–Aldrich) in water and characterized as previously
escribed (Coradeghini et al., 2013)..2. Cell culture conditions
Immortalized mouse ﬁbroblast cell line (Balb/3T3) was  used as described by
oradeghini et al. (2013).ers 228 (2014) 111–126
2.3. Cell fractionation
1 × 106 Balb/3T3 cells were seeded in 5 mL complete culture medium
(100 × 20 mm Petri dish, Corning, Italy) in three replicates for each experimen-
tal  condition. After 24 h, the medium was replaced and 5 and 15 nm AuNPs were
added to obtain the ﬁnal concentrations of 300 M (58.8 g/mL). In each experiment
untreated cells were used as control.
In order to minimize proteolysis effects and artifactual cross-linking by disul-
ﬁde bridges of proteins, all buffers were supplemented with 5 mM Na2S2O5, 1 mM
phenylmethylsulfonyl ﬂuoride (PMSF), 0.5 mM benzamidine, 20 g/mL leupeptin,
10  g/mL pepstatin A, 25 g/mL aprotinin and 1 mM dithiothreitol (DTT). All the
steps were carried out at 4 ◦C.
After 72 h of exposure, the supernatant was collected and kept for SPR analy-
sis,  while the cells were washed with phosphate-buffered saline (PBS, Invitrogen,
Carlsbad, CA, USA), mechanically harvested with a sterile plastic disposable cell
scraper and recovered by centrifugation at 4000 × g for 15 min. Then, the cell pel-
let  was washed twice in 40 mL and then 10 mL  of PBS, centrifuged and processed
as  follows. Cell lysates were obtained by resuspending the cellular pellet in 500 L
of  Lysis buffer (20 mM Tris–HCl pH 7, 100 mM NaCl, 1 mM EDTA, 0.5% Triton X-
100). The solution was  kept under weak agitation at 4 ◦C for 20 min. The lysate
was recovered by centrifugation at 15,000 × g for 15 min. The supernatant, corre-
sponding to the cytoplasmic extracts, was  transferred into a new tube and incubated
with equal volume of a 20% sodium dodecyl sulfate (SDS) and 6% DTT solution in
milli-Q water, sonicated on ice for 15 s, then heated at 95 ◦C for 5 min. After cen-
trifugation at 13,000 × g for 15 min, the supernatant was recovered. All the samples
were delipidated and cleaned (Candiano et al., 2004). The samples were then solu-
bilized with 8 M urea, 1 M thiourea, 4% (w/v) CHAPS, 65 mM DTT, 0.1 mM EDTA and
40  mM Tris–HCl (pH 8.8) for two-dimensional polyacrylamide gel electrophoresis
(2D-PAGE). All the reagents were supplied by Sigma–Aldrich.
Protein concentration was determined using the Bio-Rad (Bio-Rad Laboratories,
Hercules, CA, USA) protein microassay with bovine serum albumin as a calibration
standard.
For each experimental condition (control, 5 and 15 nm AuNPs) six biological
replicates were run in parallel.
2.4. 2D gel electrophoresis
Two-dimensional analysis was  performed by isoelectric focusing (IEF) followed
by  high-resolution two  dimensional polyacrilamide gel electrophoresis (Barboro
et al., 2008). After electrophoresis, the gels were stained with the Sybro Ruby ﬂu-
orescent protein gel stain (Molecular Probes, Eugene, OR, USA) for protein pattern
analysis or further Western blotting (WB) experiments.
Block randomized design on six biological replicates for each experimental con-
dition (control, 5 and 15 nm AuNPs) was  performed to reduce the bias and variance
in  the 2D-gel protein patterns in order to better estimate the difference between
untreated and AuNPs treated cells (Cairns, 2011).
2.5. Differential image analysis of 2D gel protein patterns
All Sybro Ruby-stained 2D gels were digitized with a GS-800 imaging densito-
meter (BioRad, Hercules, CA, USA) using the same scanning conditions. Background
subtraction, spot detection, gel alignment and spot matching were performed using
the PDQuest 2D analysis software package (Ver. 7.3.0, BioRad). To compensate for
subtle differences in sample loading and gel staining, the volume of each spot was
normalized according to the quantity in valid spots in each gel. The 2D gels were
grouped into three classes (control, 5 and 15 nm AuNPs) and differential analysis
was performed on logarithmic transformed data to improve the variance across all
spots in a gel (Dowsey et al., 2010). The Mann–Whitney test was  performed for
every matched spot, comparing the median and the median deviation of protein
abundance (treated vs control) for a given spot. The Mann–Whitney test is a non-
parametric test that compares two unpaired groups, and returns the list of spots with
a  p value smaller than 0.05 giving clear evidence that the population medians are dif-
ferent. Values of the spot volume ratio falling outside the range of ±2-folds change
were regarded as being signiﬁcantly different between control and treated samples.
All differentially expressed spots were then individually re-examined to ensure
that  they were of high quality. The ratio of the spot volumes between two  classes
(control vs 5 nm AuNPs and control vs 15 nm AuNPs) was accurately calculated for
each spot using the median value. This quantitative parameter indicates the change
in  protein abundance between control and treated samples. For a correct and mean-
ingful quantitative analysis, only proteins present in at least four of the six replicate
gels were used for further investigation (LC–MS/MS identiﬁcation and biological
data interpretation).
2.6. Preparative 2D gels
A preparative gel was run using 200 g of pooled protein from control or 5 nm
AuNPs treated samples. Experimental conditions for electrophoresis were the
same as the ones described for analytical gel. The gels were Sypro Ruby stained
and digitized for image analysis. Preparative gels were matched with analytical
gels  for protein selection in the 2D map  using PDQuest software. Corresponding
spots were listed and numbered accordingly for further LC–MS/MS identiﬁcation.
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elected protein spots were excized and transferred to a 96-well plate using a
roteomeWorks Plus Spot Cutter System (BioRad).
.7. Protein hydrolysis and peptide extraction from 2D gel spots
Sample preparation was  carried out under a laminar ﬂow cabinet using powder-
ree gloves and sterile equipment. Protein spots were washed three times with
illi-Q water and dried three times with acetonitrile (CH3CN), reduced (using
0  mM DTT in 50 mM ammonium bicarbonate for 30 min  at 56 ◦C) and alky-
ated (using 50 mM iodoacetamide in 50 mM ammonium bicarbonate for 30 min
n  the dark). The enzymatic digestion (using 1 ng/L sequencing grade trypsin in
0  mM ammonium bicarbonate) was performed at 37 ◦C overnight. The resulting
ydrolysates were extracted three times in a total volume of 40 L solution of 50 mM
mmonium bicarbonate and 5 mM calcium chloride and transferred into eppendorf
ubes. Gel pieces were dehydrated by adding a total volune of 40 L CH3CN. Extracts
ere combined (80 L) and samples were evaporated to dryness using a rotary evap-
rator equipped with a vacuum system and re-suspended in 20 L solution of 0.1%
ormic acid (HCOOH) in Milli-Q water:methanol, 95:5.
.8. Capillary-LC and LTQ Orbitrap mass spectrometry
Liquid chromatography coupled to high-resolution mass spectrometry analyses
LC–MS/MS) were performed on an Ultimate 3000 micro ﬂow-liquid chromatog-
aphy system (Dionex, Sunnyvale, CA, USA) coupled on-line with a LTQ Orbitrap
L Fourier transform mass spectrometer (Thermo Scientiﬁc, Waltham, MA,  USA)
quipped with a nano-electrospray ionization source. A 96-well plate containing
ryptic peptides of the selected protein spots was loaded on the autosampler of the
C system. The binary (loading and micro pumps) LC system was  operated with
hromeleon software (Dionex) at a ﬂow rate of 400 L/min and a ﬂow of 4 L/min
as  obtained after a 1:100 capillary ﬂow split (Dionex).
Peptide mixtures from the trypsin digest were injected by the autosampler and
oaded (using the loading pump) on a on a Dionex Acclaim PepMap C18 cartidge
300 m × 50 mm,  5 m) for desalting and pre-concentration for 4 min. A post-
njection switch valve was  activated at 4.01 min, and a binary gradient was  generated
sing the micro pump. Peptides were eluted from the trap column with increasing
rganic phase (CH3CN), and separated on a Dionex Acclaim PepMap C18 capillary
olumn (300 m × 150 mm,  3 m,  190 A˚). The eluents used were (A) 0.1% HCOOH in
illi-Q H2O and (B) 0.1% HCOOH in CH3CN. The loading pump was  operated in the
socratic mode (0–4 min, 95% A). The multi-step gradient used to achieve the pep-
ides separation was  as follows: 0–4 min, 95% A; 4–30 min, 95–50% A; 30–38 min,
0–10% A; 38–43 min, 10% A; 43–44 min, 10–95% A; 44–60 min: 95% A. The eluted
eptides were sprayed directly from the tip of the capillary column to the mass
pectrometer for mass spectrometry analysis.
The LTQ Orbitrap instrument was operated with Xcalibur software (Thermo Sci-
ntiﬁc) in the DDA (data dependent analysis) mode. In parallel to MS acquisition in
he  Orbitrap (Event 1), the MS/MS  fragmentation of the ﬁve most abundant precur-
or ions (top ﬁve mode) was  simultaneously achieved in the ion trap (Event 2). For
vent 1, a mass range of 400–2000 was selected for the Orbitrap, a resolution of
0,000 was  set (average scan time of 1 s) and data were acquired in the continuum
ode. For event 2, a mass range of 50–2000 was  selected with the ion trap and
ata were acquired in the centroid mode. Fragmentation scans were done with CID
collision induced dissociation).
In this way, masses of both the parent peptide and its daughter ions were
etected. The accurately measured masses of the tryptic peptide and its fragments
ere used to search for protein candidates in protein sequence databases.
.9. Protein database searching parameters
The fragment ion spectra obtained in the data dependent analysis mode were
rocessed using Xcalibur software (Thermo Scientiﬁc). Peptide mass lists were
ubmitted to database search (Swiss-Prot/Uniprot) using Proteome Discoverer
Thermo Scientiﬁc) and Mascot Distiller (Matrix Science, Columbia, SC, USA)
earch engines. Results obtained with Proteome Discoverer were confronted to
he  one obtained with Mascot Distiller. Proteins were identiﬁed by correlation
f  processed mass spectral data to protein entries. The main search parameters
ere: enzyme, trypsin; no restriction on molecular weight and pI; taxonomy,
ouse (in the case of mascot distiller); two  missed cleavage allowed; tolerance
n  the precursor mass: 10 ppm; tolerance on fragment mass, 0.8 Da; variable
odiﬁcations: carbamidomethylation of cysteine, oxidation of methionine; other
otential modiﬁcations could also be considered.
After databank searching and sequence analysis each identiﬁed peptide was
ssigned a peptide score and a probability based score algorithm, which gave an
ndication for the reliability of the peptide identiﬁcation. Proteins listed as signiﬁcant
atches in the Proteome Discoverer and Mascot Distiller search results were further
onsidered as good candidates for identiﬁcation if the following conditions were
et: (a) sequence coverage of at least 5%, (b) fair agreement of theoretical MW and
I  with the respective experimental values obtained from 2D gel image analysis
differences allowed: 25% for MW and 10% for pI), (c) probability score of at least
0. If more than one protein met  the above criteria for a given spot, the protein with
he highest number of matched peptides was retained.ers 228 (2014) 111–126 113
2.10. Pathway analysis
Relation between the identiﬁed proteins was evaluated using the software Inge-
nuity Pathway Analysis (IPA, Ingenuity Systems, Redwood City, CA, USA). Identiﬁed
proteins were mapped onto Ingenuity’s Knowledge Database to generate networks
on the base of their algorithmic connectivity. Canonical pathways analysis identi-
ﬁed the pathways from the IPA library that were most signiﬁcant to the data set, on
the basis of the number of molecules from the data set that map  to the pathway.
Functional analysis of networks found out the biological functions that were most
signiﬁcant to the molecules in the network (p value <0.01, right-tailed Fisher’s exact
test).
2.11. 2D-Western blotting and detection of phosphorylated proteins
In the case of 5 nm AuNPs and untreated cells, proteins extracts were separated
by  2D-PAGE, transferred to a Hybond-P membrane (GE Healthcare, Waukesha, WI,
USA) and immunodetection was carried out as already described (Alberti et al., 2000)
using the antibodies reported in Supplementary Material Table S1.
Multiplexed staining was also performed to evaluate the total level of phos-
phorylation of the whole cytoplasmic extracts. The gels were incubated with a
phosphoprotein-speciﬁc gel stain (Pro-Q Diamond, Molecular Probes), and then
stained for total proteins visualization using Sypro Ruby protein gel stain (Molecular
Probes), as recommended by the manufacturer. Using PDQuest analysis software to
compare the two  patterns, phosphoproteins spots in Pro-Q gel could be matched
with protein spots in replica Sypro-Ruby stained gels.
2.12. Transmission electron microscopy (TEM) analysis
Samples were prepared as described by Coradeghini et al. (2013).
2.13. Surface plasma resonance (SPR) analysis
SPRi-Biochips (Horiba Scientiﬁc, Irvine, CA, USA) for SPR analysis were charac-
terized by 5 nm of Ti followed by 45 nm of Au.
The Au surface of the prism was functionalized with 5 mM 16-
mercaptoundecahexaoic acid (Sigma–Aldrich) in ethanol over night at room
temperature. The carboxylic group was then activated for 20 min with 4% N-ethyl-
N′-(dimethilaminopropyl)-carbodiimide (EDC) and 0.1 M of N-hydroxysuccinimide
(NHS) (both from Sigma–Aldrich), solubilized in Milli-Q water (Millipore,
Billerica, MA,  USA). After activation, 0.1 mg/mL of antibodies anti-collagen I and
anti-ﬁbronectin (Life Technologies, Carlsbad, CA, USA) were diluted in 50 mM MES
pH 5.5 containing 5% (v/v) glycerol at different concentrations, and spotted on acti-
vated gold surface with the sciFLEXARRAYER microspotter (Scienion AG, Germany).
Antibodies anti-maltose binding protein (MBP), at the same concentration, were
also spotted on the same chip, as negative control in order to test the speciﬁcity.
The chips were then washed with PBS for 10 min, rinsed with Milli-Q water, dried
with N2 and transferred into the SPR system.
SPR measurements were performed with SPRi-PLEX+ instrument (Genoptix Bio-
Pharma Services, Carlsbad, CA, USA), equipped with a 12-bit charge-coupled-device
(CCD) camera.
The plasmon resonance was achieved with the Kretschmann conﬁguration
using an incident-light beam with a ﬁxed wavelength of 810 nm (Kretschmann and
Raether, 1968). For SPR measurements, the areas of interest were selected using a
CCD image; in this step, both position and size of the different areas of interest were
determined. Then, the angle of the incident light beam with the sample surface was
varied from 530◦ to 630◦ with a step of 0.30◦ and the plasmon curves from each area
of  interest were obtained. The working angle was then determined as the maximum
of  the ﬁrst derivative of the reﬂectance as a function of the angle of incidence. The
working temperature was ﬁxed at 25 ◦C.
The supernatants of 5 and 15 nm AuNPs treated and untreated cells, obtained
as  previously described in cell fractionation section, were centrifuged at 18,000 × g
for  30 min  at 4 ◦C, and properly diluted at 1:10 in PBS containing 0.1% Tween-20
(Sigma–Aldrich). A volume of 100 l of each dilution was injected in the system
at  a ﬂow rate of 20 l/min using an automated injector (ChemiLab, Venezia, Italy).
Protein interaction was  monitored from each area of interest by plotting the reﬂec-
tivity changes versus time (sensogram) at the working angle previously selected.
Variations at the interface of the reﬂected light were monitored by the CCD camera
at  a ﬁxed angle of 58.55◦ . The software allowed getting the difference image before
and after the immobilization of the molecules on the interface. The binding kinetic
was monitored over-time.
Results are presented as mean of three independent experiments. SPR senso-
grams were analyzed by Scrubber software (BioLogic Software, Campbell, Australia).
3. ResultsA scheme summarizing the experimental approach used to
investigate cellular responses to 5 and 15 nm AuNPs exposure is
shown in Fig. 1.
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Fig. 1. Experimental overview. Citrate stabilized 5 and 15 nm AuNPs were characterized as previously reported (Coradeghini et al., 2013). 2D-PAGE combined with protein
identiﬁcation by LC–MS/MS was used to analyze the differentially expressed proteome of the cytoplasmatic compartment of Balb/3T3 cells exposed to 5 and 15 nm AuNPs
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.1. Analysis of the differentially expressed proteins
By two-dimensional analysis we assessed the differences in the
ytoplasmatic proteome of Balb/3T3 cells exposed to 5 and 15 nm
uNPs in respect to the control (untreated cells) (Fig. 2A–C). The
nalysis of imaged gels identiﬁed a total of 722, 614 and 588 protein
pots for the three classes respectively, namely control, Au5 (5 nm
uNPs) and Au15 (15 nm AuNPs) (Fig. 2D).
The Mann–Whitney test was used to compare the overall pro-
ein expression proﬁle. Among the protein spots detected, 64
rotein spots were found down-regulated by at least 2-folds, and
4 were up-regulated by at least 2-folds in cells treated with 5 nm
uNPs. 47 and 36 spots were shown decreased and increased by
t least 2-folds in cells treated with 15 nm AuNPs, respectively.
mong the down-regulated proteins, 25 were in common with both
roups, while only three were found up-regulated in both groups
Fig. 2D). A total number of 143 proteins were found differentially
xpressed as compared to the control.
Interestingly, our analysis revealed that ca. 14% of the cytoplas-
ic  proteome was signiﬁcantly altered following AuNPs exposure
or 72 h. In addition, particle size deeply inﬂuenced dysregulation
f protein expression, as only 30% of the de-regulated proteins were
ound to be common to both treatments.
.2. Identiﬁcation of the differentially expressed proteins by
C–MS/MS
Proteins of interest (up- or down-regulated) were deﬁned
rom the images of the control and treated samples, and theiriplex staining was  used to analyze the differentially phosphorylated proteins. The
NPs and the autophagy process were also investigated by TEM analysis and Western
corresponding spots in the image of the preparative gel were
matched. However, due to the low sensitivity of the integrated UV
detection system of the spot picker, of the 143 spots, only ca. 43%
could be visualized in the preparative gel and picked for further MS
identiﬁcation.
Hence, a total of 61 spots were selected from the preparative gel
for spot picking. The aforementioned de-regulated protein targets
were analyzed using LC–MS/MS.
Proteome Discoverer (Thermo Scientiﬁc) with the Sequest
workﬂow and SwissPro/Uniprot database was used for protein
identiﬁcation of the selected de-regulated protein spots (Table 1,
spots numbered A1–F1). As a taxonomy error was in some cases
detected, results were further validated using the database search
engine Mascot Distiller (Matrix Science), with a restricted work-
ﬂow using the taxonomy of the organism (Mus  musculus). Results
were returned for 45 of the 61 selected spots (Fig. 3). Table 2 reports
the biological functions, symbols and the level of de-regulation of
the identiﬁed proteins.
3.3. Pathway analysis
IPA analysis revealed the most signiﬁcant networks associated
with different categories of biological functions (Table 3) such as
cell death, cellular growth and proliferation, cell cycle, cellular
function and maintenance, inﬂammatory response, and cell mor-
phology. De-regulated proteins identiﬁed in this study involved in
cell death and survival mechanisms are listed in Table 4.
The canonical pathway analysis pointed out glycolysis, glucose
and aminoacids metabolism and the gap junction expression as
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Table 1
List of protein spots undergoing quantitative changes with AuNPs treatment.
Spot # Accession # Mascot Cov % Sequest Cov % Mascot unique
peptide #
Sequest unique
peptide #
MW pI Mascot
score
Sequest score Description
A1 Q91W90 29 35 12 24 46,386 5.51 165 38.46 Thioredoxin domain-containing protein 5 OS = Mus
musculus,  GN = Txndc5, PE = 1, SV = 2
A2  Q91W90 13 26 6 19 46,386 5.51 118 34.90 Thioredoxin domain-containing protein 5 OS = Mus
musculus,  GN = Txndc5, PE = 1, SV = 2
A4  Q8BFR5 5 12 3 7 49,477 7.23 63 16.31 Elongation factor Tu, mitochondrial OS = Mus musculus,
GN = Tufm, PE = 1, SV = 1
A5  P52480 50 48 33 73 57,808 7.18 711 194.89 Pyruvate kinase isozymes M1/M2  OS = Mus  musculus,
GN = Pkm2, PE = 1, SV = 4
A6  Q9Z247 15 15 13 19 62,955 5.03 127 29.82 Peptidyl-prolyl cis-trans isomerase FKBP9 OS = Mus
musculus,  GN = Fkbp9, PE = 1, SV = 1
A7  P57776 28 26 8 20 31,274 4.91 187 63.54 Elongation factor 1-delta OS = Mus  musculus, GN = Eef1d,
PE  = 1, SV = 3
A8  Q9DBG5 46 35 23 38 47,233 5.45 742 124.52 Perilipin-3 OS = Mus  musculus, GN = Plin3, PE = 1, SV = 1
A10  Q99KI0 33 35 29 50 85,410 8.08 417 115.47 Aconitate hydratase, mitochondrial OS = Mus  musculus,
GN = Aco2, PE = 1, SV = 1
A11  Q99KI0 36 32 26 36 85,410 8.08 298 80.29 Aconitate hydratase, mitochondrial OS = Mus  musculus,
GN = Aco2, PE = 1, SV = 1
B1  P13020 8 13 5 14 85,888 5.83 176 34.31 Gelsolin OS = Mus  musculus, GN = Gsn, PE = 1, SV = 3
B3  Q76MZ3 12 20 6 17 65,281 5 191 4396 Serine/threonine-protein phosphatase 2A 65 kDa
regulatory subunit A alpha isoform OS = Mus  musculus,
GN = Ppp2r1a, PE = 1, SV = 3
B4  P11087 40 38 39 52 137,948 5.65 658 119.49 Collagen alpha-1(I) chain OS  = Mus  musculus, GN = Col1a1,
PE  = 1, SV = 4
B5  P40142 20 13 11 10 67,588 7.23 126 26.6 Transketolase OS = Mus  musculus, GN = Tkt, PE = 1, SV = 1
B6  Q8CHH9 32 35 10 21 49,781 5.68 153 38.4 Septin-8 OS = Mus  musculus, GN = Sept8, PE = 1, SV = 4
B9  Q9CWJ9 43 41 22 41 64,177 6.3 483 108.07 Bifunctional purine biosynthesis protein PURH OS = Mus
musculus, GN = Atic, PE = 1, SV = 2
B11  P40142 44 40 26 45 67,588 7.23 361 114.8 Transketolase OS = Mus  musculus, GN = Tkt, PE = 1, SV = 1
B12  P57776 30 26 6 4 31,274 4.91 173 38.7 Elongation factor 1-delta OS = Mus  musculus, GN = Eef1d,
PE  = 1, SV = 3
C1  P13020 13 9 10 12 85,888 5.83 135 31.5 Gelsolin OS = Mus  musculus, GN = Gsn, PE = 1, SV = 3
C2  Q3TW96 6 5 4 5 56,578 5.27 30 5.80 UDP-N-acetylhexosamine pyrophosphorylase-like protein
1 OS = Mus  musculus, GN = Uap1l1, PE = 2, SV = 1
C3  P48036 55 53 23 44 35,730 4.83 438 109.90 Annexin A5 OS = Mus  musculus, GN = Anxa5, PE = 1, SV = 1
C4  P80316 39 42 17 38 59,586 5.72 401 108.09 T-complex protein 1 subunit epsilon OS  = Mus musculus,
GN  = Cct5, PE = 1, SV = 1
C5  P58252 14 24 15 47 95,253 6.41 163 114.84 Elongation factor 2 OS = Mus  musculus, GN = Eef2, PE = 1,
SV = 2
C6  P63028 24 24 6 15 19,450 4.76 101 36.01 Translationally-controlled tumor protein OS  = Mus
musculus,  GN = Tpt1, PE = 1, SV = 1
C7  P17182 24 26 9 19 47,111 6.37 171 40.14 Alpha-enolase OS = Mus  musculus, GN = Eno1, PE = 1, SV = 3
C8  P56480 23 58 19 120 56,265 5.19 592 401.49 ATP synthase subunit beta, mitochondrial OS  = Mus
musculus,  GN = Atp5b, PE = 1, SV = 2
C9  P58252 31 32 26 58 95,253 6.41 484 156.33 Elongation factor 2 OS = Mus  musculus, GN = Eef2 PE = 1,
SV = 2
C10  O88844 45 49 19 40 46,644 6.73 374 113.61 Isocitrate dehydrogenase [NADP] cytoplasmic OS = Mus
musculus,  GN = Idh1, PE = 1, SV = 2
C11  Q5XJF8 11 44 16 105 50,104 4.94 268 275.42 Tubulin alpha-1A chain OS = Mus  musculus, GN = Tuba1a,
PE  = 1 SV = 1
C12  P09103 52 54 54 114 57,023 4.77 802 289.74 Protein disulﬁde-isomerase OS = Mus  musculus, GN = P4hb,
PE  = 1, SV = 2
D7  P60335 9 DNF 3 DNF 37,474 6.66 122 DNF Poly(rC)-binding protein 1 OS = Mus  musculus, GN = Pcbp1,
PE = 1, SV = 1
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Table 1 (Continued)
Spot # Accession # Mascot Cov % Sequest Cov % Mascot unique
peptide #
Sequest unique
peptide #
MW pI Mascot
score
Sequest score Description
D10 P10649 7 DNF 2 DNF 25,953 7.71 56 DNF Glutathione S-transferase Mu  1 OS = Mus  musculus,
GN = Gstm1, PE = 1, SV = 2
D11  Q64727 17 19 17 18 116,644 5.77 321 68.69 Vinculin OS = Mus  musculus, GN = Vcl, PE = 1, SV = 4
D12  Q02257 5 DNF 4 DNF 81,749 5.75 152 DNF Junction plakoglobin OS = Mus  musculus GN = Jup PE = 1
SV = 3
E1  Q8BMD8 8 8 4 4 52,868 7.02 88 52.9 Calcium-binding mitochondrial carrier protein SCaMC-1
OS = Mus  musculus, GN = Slc25a24, PE = 2, SV = 1
E2  P08030 5 22 1 3 19,724 6.31 59 17.85 Adenine phosphoribosyltransferase OS = Mus  musculus,
GN = Aprt, PE = 2, SV = 1
E3  Q8WUC1 16 49 8 15 49,639 4.78 260 16,36 Tubulin beta-5 chain OS = Mus  musculus, GN = Tubb5, PE = 1,
SV  = 1
E4  P05202 7 27 4 6 47,381 9.13 131 43.08 Aspartate aminotransferase, mitochondrial OS = Mus
musculus,  GN = Got2, PE = 1, SV = 1
E5  Q3U9G0 16 28 11 16 70,827 5.37 205 64.83 Heat shock cognate 71 kDa protein OS = Mus  musculus,
GN = Hspa8, PE = 1, SV = 1
E6  P35700 31 31 7 7 22,162 8.26 154 26.84 Peroxiredoxin-1 OS = Mus  musculus, GN  = Prdx1, PE = 1,
SV = 1
E7  P19324 18 41 12 13 46,504 8.88 128 101.63 Serpin H1 OS  = Mus  musculus, GN = Serpinh1, PE = 1, SV = 3
E9  Q99K85 22 29 9 9 40,447 8.15 165 38.62 Phosphoserine aminotransferase OS = Mus  musculus,
GN = Psat1, PE = 1, SV = 1
E10  P16858 10 34 4 8 35,787 8.44 159 56.54 Glyceraldehyde-3-phosphate dehydrogenase OS = Mus
musculus,  GN = Gapdh, PE = 1, SV = 2
E11  P56399 6 12 5 8 95,772 4.89 198 60.59 Ubiquitin carboxyl-terminal hydrolase 5 OS = Mus
musculus, GN = Usp5, PE = 1, SV = 1
E12  Q9CWJ9 7 DNF 4 DNF 64,177 6.3 95 DNF Bifunctional purine biosynthesis protein PURH OS  = Mus
musculus,  GN = Atic, PE = 1, SV = 2
F1  Q569X5 10 34 4 8 35,787 8.44 141 47.68 Glyceraldehyde-3-phosphate dehydrogenase OS = Mus
musculus,  GN = Gapdh, PE = 1, SV = 2
The identities of individual protein spots obtained by 2D-PAGE (A1–F1 in Fig. 2) were analyzed by MS.  Peptide mass lists were submitted to database search (Swiss-Prot/Uniprot) using Proteome Discoverer and Mascot Distiller
search  engines, as described in Section 2. The UniProt accession number, the protein coverage, the number of unique identiﬁed peptides, the molecular mass (MW), isoelectric point (pI)  and the probability score are shown.
DNF  = data not found using the corresponding workﬂow.
S. Gioria et al. / Toxicology Letters 228 (2014) 111–126 117
Table  2
Description of the de-regulated protein spots and their biological/molecular functions.
Spot # 5 nm AuNPs 15 nm AuNPs Symbol Description Biological process/molecular function
A1 − − − − − − TXNDC5 Thioredoxin domain-containing protein 5 Cell redox homeostasis
A2  − − − − − − TXNDC5 Thioredoxin domain-containing protein 5 Cell redox homeostasis
A4  − − − − TUFM Elongation factor Tu, mitochondrial Protein biosysnthesis
A5  − × Pkm Pyruvate kinase isozymes M1/M2 Glycolisis
A6  × − − − FKBP9 Peptidyl-prolyl cis–trans isomerase FKBP9 Protein folding
A7  − − − − EEF1D Elongation factor 1-Tu Protein biosynthesis
A8  + + + + + + PLIN3 Perilipin-3 Transport required for the transport of
mannose 6-phosphate receptors (MPR) from
endosomes to the trans-golgi network
A10  − − − − ACO2 Aconitate hydratase, mitochondrial Tricarboxylic acid cycle
A11  − × ACO2 Aconitate hydratase, Tricarboxylic acid cycle
B1  × − − − GSN Gelsolin Actin ﬁlament capping, actine ﬁlament
polymerization, vesicle-mediated transport
B3  × − − PPP2R1A Serine/threonine-protein phosphatase 2A
65 kDa regulatory subunit A alpha isoform
Chromosome partition (cell division)
B4  × + COL1A1 Collagen alpha-1(I) chain Protein transport, cellular response to
mechanical stimulus, collagen ﬁbril
organization
B5  − − − − − − TKT Transketolase Regulation of growth
B6  − − − − SEPT8 Septin-8 Cell cycle
B9  × − ATIC Bifunctional purine biosynthesis protein
PURH
Purine biosynthesis
B11  − − − − − − TKT Transketolase Regulation of growth
B12  − − − − − − EEF1D Elongation factor 1-delta Protein biosynthesis
C1  − − − − GSN Gelsolin Actin ﬁlament capping, actin ﬁlament
polymerization, vesicle-mediated transport
C2  − − − − − − UAP1L1 UDP-N-acetylhexosamine
pyrophosphorylase-like protein 1
Nucleotidyltransferase activity
C3  + + ANXA5 Annexin A5 Role in autophagy process
C4  − − CCT5 T-complex protein 1 subunit epsilon Protein folding
C5  − − − × EEF2 Elongation factor 2 Protein biosynthesis
C6  − − − − − − TPT1 Translationally-controlled tumor protein Anti-apoptosis
C7  − − − − − − ENO1 Alpha-enolase Glycolisis
C8  + × ATP5B ATP synthase subunit beta, mitochondrial ATP synthesis
C9  − − × EEF2 Elongation factor 2 Protein biosynthesis
C10  − − IDH1 Isocitrate dehydrogenase [NADP]
cytoplasmic
Glyoxylate cycle, tricarboxylic acid cycle,
response to oxidative stress, isocitrate
metabolic process
C11  × − TUBA1A Tubulin alpha-1A chain microtubule-based movement, protein
polymerization
C12  − × P4HB Protein disulﬁde-isomerase Cell redox homeostasis, glycerol ether
metabolic process
D7  − × PCBP1 Poly(rC)-binding protein 1 mRNA processing
D10  × + GSTM5 Glutathione S-transferase Mu  1 Cellular response to drug, molecular
Glutathione transferase activity
D11  − − − − − − VCL Vinculin Cell adhesion
D12  − − − − JUP Junction plakoglobin Cell–cell adhesion, cytoskeletal anchoring at
plasma membrane, cell morphogenesis
E1  − − − − SLC25A24 Calcium-binding mitochondrial carrier
protein SCaMC-1
Transmembrane transport
E2  − − − − − − APRT Adenine phosphoribosyltransferase Purine salvage
E3  − − − − − − TUBB5 1Tubulin beta-5 chain B Microtubule-based movement, protein
folding, protein polymerization
E4  − × GOT2 Aspartate aminotransferase, mitochondrial Aspartame biosynthetic process, fatty acid
transport
E5  × + HSPA8 Heat shock cognate 71 kDa protein Stress response
E6  − − − − − PRDX1 Peroxiredoxin-1 Regulation of stress-activated MAPK cascade,
removal of superoxide radicals, cell
proliferation
E7  − − − × SERPINH1 Serpin H1 Collagen biosynthetic process, response to
stress
E9  − − − − − PSAT1 Phosphoserine aminotransferase Amino-acid biosynthesis
E10  − − − − Gadph Glyceraldehyde-3-phosphate
dehydrogenase
Glycolisis, microtubule cytoskeleton
organization, protein stabilization
E11  × − − − USP5 Ubiquitin carboxyl-terminal hydrolase 5 Ubiquitin-dependent protein catabolic process
E12  − × ATIC Bifunctional purine biosynthesis protein
PURH
Purine biosynthesis
F1  − − − − − − Gadph Glyceraldehyde-3-phosphate
dehydrogenase
Glycolisis, microtubule cytoskeleton
organization, protein stabilization
List of protein spots undergoing quantitative changes in response to AuNPs treatments (as numbered in Table 1). Protein symbol, description and biological process or
molecular function are speciﬁed. AuNPs de-regulation is reported and indicated as: −: downregulation; +: upregulation; − or +: 2≤ |fold change| <5; − − or + +: 5≤ |fold
change|  <10; − − − or + + + |fold change| ≥10; ×: <2-fold change.
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Fig. 2. Proteomic analysis of Balb/3T3 exposed to AuNPs. Representative two-dimensional gel protein maps of cytoplasmic fractions of (A) untreated (Ctrl), (B) treated with
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n nm AuNPs, and (C) treated with 15 nm AuNPs Balb/3T3 cells for 72 h. (D) Venn d
Au5  and Au15) and untreated (Ctrl) cells. Percentages of matched spots among th
reated  cells in respect to the control (P vs ctrl) are also reported.
he main pathways where the identiﬁed proteins are involved in
Fig. 4). Moreover, IPA analysis shows that several of the proteins
dentiﬁed as de-regulated in Balb/3T3 cells by AuNPs treatment are
inked to oxidative stress responses (Fig. 5).
able 3
PA networks.
ID Molecules in network 
1 Alpha catenin, ANXA5, ATP5B, Beta Tubulin, Caspase, CCT5, CD3, COL1A1,
Collagen type I, Collagen(s), EEF2, ENO1,  ERK, ERK1/2, FActin, FSH, GOT2, G
HSPA8,  Jnk, JUP, Lh, P4HA2, P4HA3, P4HB,  PI3K (complex), Pkm, PLIN3,
PPP2R1A,  PRDX1, PSAT1, SERPINH1, TPT1 (includes EG:100043703),
TUBA1A,  VCL
2  ACO2 (includes EG:11429), APRT, ARAF, ATIC, CACNA1B, CAPN2, CCND1,
EEF1D,  EGF (includes EG:13645), EGFR, GAK, GSTM5,  HSPBP1, HSPH1, IDH
JUN, MAP4, MAP3K1, MAPK3, NRAS, PCBP1, Pkc(s), PRDX1, PRKCZ,
prostaglandin F2alpha, RTN4, S100A1 (includes EG:20193), SDC3, SEPT8,
SPG20, TKT, TUBA1A, TUFM,  USP5, VIL1
3  CAMP, FKBP9, Gapdh, HIF1A, hydrogen peroxide, IFNB1 (includes EG:1597
IFNG (includes EG:15978), MYC, NOS2, PIN1, PPIB, RNA polymerase II, TP53
(includes EG:22059)
4  THOC3, TXNDC5, XBP1 (includes EG:140614), YOD1 
5  CYC1, let-7a/let-7f/let-7c (includes others), RORA, RORC, SLC25A24 
he table reports the most signiﬁcant protein networks in response to AuNPs treatment by
umber, the list of all proteins involved in the network, the number of molecules overla
etwork  are shown (focus molecules are indicated in bold). is showing the distribution of differentially expressed proteins in AuNPs treated
experimental replicates and the signiﬁcant differences in the proteome of AuNPs
The direct link between the de-regulated identiﬁed proteins
and the connection between de-regulated identiﬁed proteins
and ubiquitin are reported in the supplementary information
(Supplementary Material: Figs. S1 and S2, respectively).
Focus molecules Top functions
SN,
20 Cell death, cellular growth and
proliferation, cell cycle
1,
13 Cell cycle, cell-to-cell signaling and
interaction, cellular function and
maintenance
7), 2 Cell death, cellular function and
maintenance, inﬂammatory response
1 Cell morphology, cellular assembly and
organization, cellular growth and
proliferation
1 Cell-mediated immune response,
cellular development, cellular function
and maintenance
 analysing the differentially expressed protein listed in Tables 1 and 2. The network
pping between our dataset and the network and the top functions related to the
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Table  4
De-regulated proteins involved in cell death and survival mechanisms.
Category Functions annotation p-Value Molecules Molecules #
Cell death and survival Apoptosis 2.81E−02 EEF1D, ENO1, GSN, GSTM5, JUP, PPP2R1A, SLC25A24, TPT1, VCL 9
Cell  death and survival Cell death 2.58E−03 APRT, CCT5, EEF1D, ENO1, GSN, GSTM5, HSPA8, JUP, PPP2R1A,
PRDX1, SLC25A24, TPT1, VLC
13
Cell  death and survival Necrosis 1.53E−02 APRT, C
The table shows the list of de-regulated proteins identiﬁed in this study involved in cell de
Fig. 3. Selection of differentially expressed proteins. Sypro Ruby stained gel of cyto-
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A small portion of the protein lysates of untreated and 5 nm
AuNPs treated cells were subjected to two-dimensional SDS-PAGElasmic proteins extracted of untreated Balb/3T3 cells. The 45 identiﬁed protein
pots are highlighted in circles and are marked with spot numbers as speciﬁed in
ables 1 and 2..4. Differential analysis of phosphorylated proteins
The total level of phosphorylation of the cytoplasmatic pro-
eins was examined in untreated and 5 nm AuNPs treated Balb/3T3
ig. 4. Top 10 canonical pathways modiﬁed in response to AuNPs. Bar chart
resenting the top 10 canonical pathways in response to 5 and 15 nm AuNPs treat-
ents obtained by analyzing the differentially expressed protein targets (listed in
ables 1 and 2) using IPA. The most signiﬁcant canonical pathways are displayed
long the y-axis of the bar chart. The x-axis displays the −log of p-value which
s  calculated by Fisher’s exact test right-tailed. The ratio between the number of
roteins in our dataset and the total of proteins that make up the pathway is also
ndicated (orange dot). (For interpretation of reference to color in this ﬁgure legend,
he  reader is referred to the web version of this article.)CT5, EEF1D, ENO1, GSN, GSTM5, HSPA8, SLC25A24, TPT1 9
ath and survival mechanisms. Functions annotation and p-values are also reported.
cells by multiplexed staining using ﬁrstly Pro-Q Diamond, a
phosphoprotein-speciﬁc gel stain, and subsequentially Sypro Ruby
gel stain for total protein visualization. A quantitative compari-
son of the proteome and phosphoproteome of Balb/3T3 cells, both
untreated and exposed to 5 nm AuNPs, is reported in Fig. 6.
A distinct change in the proteins phosphorylation level was
detected in response to 5 nm AuNPs treatment: 81 spots were
found hyper-phosphorylated and 117 hypo-phosphorylated in
5 nm AuNPs treated cells with respect to the control.
Furthermore, we  focused on the identiﬁed de-regulated pro-
teins listed in Table 1, analyzing if they were subject to a change
in their phosphorylation status when compared to the control
(see Supplementary Material: Table S1). Several proteins found
to be down-regulated following 5 nm AuNPs exposure, showed to
be hyper-phosphorylated (TXNDC5, IDH1, TUFM,  ENO1). ATP5B,
responsible for ATP production in oxidative phosphorylation,
showed instead an opposite trend: over-expressed in 5 nm AuNPs,
and hypo-phosphorylated if compared to the control. FKBP9 not
listed among the de-regulated proteins, undergoes phosphoryla-
tion following exposure to 5 nm AuNPs.
3.5. Investigation of other speciﬁc proteins by 2D-Western
blottingFig. 5. Oxidative stress network. The network was generated through the use of
Ingenuity Pathway Analysis software (Ingenuity Systems). Identiﬁed de-regulated
proteins involved in oxidative stress are highlighted in bold. Continuous lines rep-
resent protein–protein interactions while the dotted ones correspond to indirect
interactions (i.e. translocation, phosphorylation). Loops represent feedback systems.
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Fig. 6. Phosphoprotein analysis. (A) Representative Pro-Q Diamond and Sypro-Ruby stained 2D maps of cytoplasm fractions from Balb/3T3 untreated cells (ctrl) and treated
with  5 nm AuNPs (Au5). Phosphoproteins were separated on 2D gels and stained with Pro-Q Diamond gel stain (upper two panels, green color). The same gel was post-stained
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n  Tables 1 and 2. (B) Quantitative comparison of the proteome and phosphoproteo
he  references to colour in this ﬁgure legend, the reader is referred to the web  versi
nd then blotted with monoclonal antibodies against clathrin and
aveolin, or polyclonal antibodies against sorting nexin-5 (SNX5)
nd LC3B. Fig. 7 shows the expression proﬁles of the above listed
roteins. Clathrin heavy chain is present in the control 2D image
ith two isoforms in the acidic region, whereas several isoforms
nd protein cleavages are present in the basic region for the
 nm AuNPs treated sample. The caveolin signal is also modiﬁed
fter 5 nm AuNPs treatment. SNX5 expression in cells exposed
o AuNPs undergoes modiﬁcation and partial cleavage. LC3B was
xpressed only in the 5 nm AuNPs treated samples and not in the
ontrol.
.6. Cell interaction and intracellular distribution of AuNPs
The interaction, the NPs distribution and the involvement of
esicular intracytoplasmic structures were assessed by TEM anal-
sis on Balb/3T3 cells exposed to 5 and 15 nm AuNPs. Fig. 8 shows
he close interaction of 5 nm AuNPs with the plasma membrane, in
roximity of a villus (Fig. 8B). After 72 h of treatment, 5 nm AuNPs
nter into the cells through cell membrane invagination (Fig. 8B, spots with altered Pro-Q staining intensity are marked with the same number used
Balb/3T3 untreated (ctrl) and 5 nm AuNPs (Au5) treated cells. (For interpretation of
this article.)
arrow). AuNPs free or in endosomal vesicles are visible in the cyto-
plasm (Fig. 8A, arrow). Fig. 8C shows vacuolar shapes rich of NPs
and, an enlarged detail (Fig. 8D, arrow), shows the internal struc-
tures similar to mitochondrial dismantled cristae. We observed that
mitochondria have a different shape when containing AuNPs. In
Fig. 8C mitochondria appear stretched and elongated if not con-
taining AuNPs, whereas of round shape with dismantled cristae if
containing AuNPs. Elongated mitochondria were already visible at
24 h (Coradeghini et al., 2013; Fig. 4F). Fig. 8E shows huge vacuoles
containing both material in the process of digestion and AuNPs.
Moreover, Fig. 8F (arrow) highlights in the cytoplasm the rough
endoplasmic reticulum greatly dilated and free ribosomes.
The cellular internalization of 15 nm AuNPs in Balb/3T3 cells
is shown in Fig. 9. After 72 h treatment with 15 nm AuNPs the
endo/lysosomal compartments are partially ﬁlled with electron
dense material. Fig. 9A shows a cytoplasm rich in vacuoles with
degradation material and myelin-like structures. Fig. 9C arrow,
points out numerous NPs on the membrane and inside of multil-
amellar vacuoles. Fig. 9B arrow, underlines free particles huddled to
the cell membrane and immediately, within the cytoplasm, dense
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them into different groups of molecular functions and biological
processes using Ingenuity IPA software, based on their functional
categories in both Gene Ontology database and Ingenuity knowl-
edge database.
Table 5
SPR analysis to access ECM production after exposure to AuNPs.
Control 5 nm AuNPs 15 nm AuNPs
Collagen type I 15.2 39.6 50.8
Fibronectin 32.6 43.7 52.1ig. 7. Investigation of speciﬁc proteins by 2D-Western blotting. Analysis of (A) c
uNPs  treated Balb/3T3 cells. Exposure time: 72 h. Proteins resolved by two-dimens
onoclonal antibodies Cl and Cv or with the polyclonal antibodies SN and LC. The l
acuoles fully loaded with AuNPs are visible. Mitochondria and
ndoplasmic reticulum dilated are also evident (Fig. 9D). Fig. 9E
rrow, clearly shows an autophagosome (double membrane) with
uNPs dispersed in. The autophagosome is probably fusing with a
ysosome to form an autolysosome. It should be noted that the inner
embrane of the autophagosome is already partially digested thus
emonstrating the presence of active lysosomal enzymes. Fig. 9F
ighlights a detail of the vacuole packed with dense material.
.7. Assessment of collagen type I and ﬁbronectin production
As Balb/3T3 cells synthesize collagen type I at relatively high rate
Goldberg, 1977), we were able to quantify by SPR the amount of
ollagen type 1, produced by cells exposed to AuNPs, bound to the
nti-collagen type I speciﬁc antibody. Fibronectin, another protein
f the ECM, was also considered in the study.
After establishing the dose-dependent response of collagen type
 and ﬁbronectin on immobilized antibodies, immunoassays were
arried out using the supernatant of Balb/3T3 cells, both untreated
nd AuNPs treated for 72 h. SPR difference images of the arrayed
ntibodies, generated by the GenOptics software (Genoptix Bio-
harma Services), after the interaction of the protein with the
ctivated surface are reported in Supplementary Material: Fig. S3.
Fig. 10 shows the dose-response of the binding of the ECM
o immobilized antibodies against collagen type I, and compares
he binding of collagen type I, produced by AuNPs treated and
ntreated cells, to the antibodies. Our data show that the surface
overage in the case of 5 and 15 nm AuNPs exposed cells was for
ollagen type I more than two and nearly four times, respectively
han for the untreated cells. By SPR analysis, the production of
bronectin was found also increased in 5 and 15 nm AuNPs treated
ells (data not shown).
From the dose-binding response, it was possible to calculate the
g/mm2 of collagen type I and ﬁbronectin which were bound to the
mmobilized antibodies (Table 5).
The supernatant of the untreated cells (control) shows, both for
ollagen type 1 and ﬁbronectin, a lower binding afﬁnity compared (Cl) and caveolin (Cv), (B) SNX5 (SN) and LC3B (LC) in untreated (ctrl) and 5 nm
gel electrophoresis were transferred to Hybond-P membranes and probed with the
sed antibodies is reported in Supplementary Material: Table S2.
to that of the AuNPs treated cells, so we can conclude that AuNPs
treatment triggers the production of both proteins of the ECM in
Balb/3T3 cells.
4. Discussion
To date, studies on how cellular processes and mechanisms are
modiﬁed in response to nanomaterials exposure are very limited.
To ﬁll this gap, we employed a proteomic approach to explore
differentially expressed proteins in response to AuNPs treatment.
To our knowledge, this is among the ﬁrst nanoproteomic stud-
ies utilizing advanced MS  techniques to elucidate the effects of
gold nanoparticles at protein expression and phosphorylation level.
The work was carried out on Balb/3T3 cells for which basal cyto-
toxicity data have already been published, including a detailed
characterization of both nanomaterials studied (Coradeghini et al.,
2013).
Nanoparticle exposure triggers a number of intrinsic cell path-
ways in response to the exogenous materials. Mapping of the
proteins altered by AuNPs–cell interactions was  our key objective
in order to understand how AuNPs affect cell biology. In addition, to
explore the known functions of the identiﬁed proteins, we classiﬁedAssessment of collagen type I and ﬁbronectin production by Balb/3T3 cells exposed
to  AuNPs. The table shows the amount (expressed as pg/mm2) of collagen type I and
ﬁbronectin which was bound to the immobilized antibodies. Data are reported also
for untreated cells (control) and refer to dilution 1:10 (see Section 2).
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Fig. 8. Transmission electron microscopy (TEM) images of Balb/3T3 cells exposed to 5 nm AuNPs at the concentration of 300 M for 72 h. Part (A) is a representative image
showing 5 nm AuNPs internalized by Balb/3T3 cells. AuNPs are visible in endosomal vesicles in the cytoplasma. Part (B) is a magniﬁcation in proximity of a villus showing the
close  interaction of 5 nm AuNPs with the plasma membrane. AuNPs of 5 nm enter into the cells through cell membrane invagination (Fig. 4B, arrow). Part (C) shows vacuolar
shapes  rich of AuNPs. Part (D) is a magniﬁcation of (C) and shows the internal structure similar to mitochondrial dismantled cristae. To observe is that mitochondria have a
different  shape when containing AuNPs. Stretched and elongated if not containing AuNPs, whereas of round shape with dismantled cristae if containing AuNPs. Elongated
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eitochondria were already visible at 24 h (Coradeghini et al., 2013, see Fig. 4F). Par
rrow  in part (F) highlights the rough endoplasmatic reticulum stress caused by p
re  clearly visible.
IPA results revealed the most signiﬁcant networks associated
ith different categories of biological functions such as cell death,
ellular growth and proliferation, cell cycle, cellular function and
aintenance, inﬂammatory response, and cell morphology.
In addition, the phosphoproteome study presented here reveals
nteresting information, as these post-translational modiﬁcations
ould play an important role in activating or not signaling cascade
echanisms. However, the speciﬁc role of these changes in the
hosphorylation status awaits further characterization, in order to
xplain their biological signiﬁcance.hows huge vacuols containing AuNPs and material in the process of digestion. The
ed AuNPs treatment. Endoplasmatic reticulum greatly dilated and free ribosomes
4.1. Oxidative stress and apoptosis
LC–MS/MS analyses showed that among the differentially
expressed proteins, several are associated with cellular stress
response pathways, including oxidative stress and apoptosis.
Among proteins involved in the above pathways, Gadph,
TXNDC5, PRDX1, SERPINH1, P4HB, HSPA8, IDH1 were found mainly
all down-regulated following AuNPs exposure. Of particular inter-
est, we found that the down-regulation of some proteins involved
in oxidative stress (PRDX1, SERPINH1, one isoform of Gadph) was
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Fig. 9. Transmission electron microscopy (TEM) images of Balb/3T3 cells exposed to 15 nm AuNPs at the concentration of 300 M for 72 h. After 72 h of treatment with
15  nm AuNPs the endo/lysosomal compartments are partially ﬁlled with electron dense material. Part (A) is a representative image showing a cytoplasm rich in vacuols with
degradation material and myelin-like structure. Part (B) highlights free particles huddled to the cell membrane. Dense vacuols fully loaded with 15 nm AuNPs are visible
in  the cytoplasma. The arrow in (C) points out numerous AuNPs on the membrane and inside of multilamellar vacuoles. Part (D) shows mitochondria and endoplasmatic
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aeticulum dilated. Part (E) (arrow) shows an autophagosome containing AuNPs. The
s  the inner membrane of the autophagosome that is already partially digested thus
acuole  packed with dense material surrounded by membrane.
uch more severe in 5 nm compared to 15 nm AuNPs treated
ells.
Not surprisingly, de-regulation of a number of proteins, such as
XNDC5 and Gadph have already been reported in previous stud-
es, whose data have been generated from a wide range of particle
ypes and cellular targets (Lai et al., 2012). This re-enforced the
merging approach to adopt a new, molecular description of toxic
ction based on identifying a substance’s effect on harmful cellular
athways, rather than interpreting the effects on cell lines (Jasmine
t al., 2010).
Based on the fact that PRDX1 is a major ROS scavenger and
 partner of ASK1 and JNK, two key components of MAPK path-
ays (He et al., 2013), we propose that PRDX1 down-regulation
ight have a combined action on the accumulation of ROS and
n the enhancement of MAPK pathway activation, leading to cell
poptosis.hagosome is probably fusing with a lysosome to form an autolysosome. To observe
nstrating the presence of active lysosomal enzymes. Part (F) is a magniﬁcation of a
All together these data can provide valuable information about
potential intracellular targets for drug design via speciﬁc nano-bio
interactions (Lai et al., 2012), and the modulation of intracellular
redox state could be an approach to enhance cancer cell sensitivity
to ROS-generating nanodrugs.
Of interest is also the down-regulation of TPT1 found in both
5 and 15 nm AuNPs exposed cells. TPT1 plays important roles in
a number of cell physiological events, such as immune responses,
cell proliferation, carcinogenicity and cell death, including apopto-
sis and recently has been identiﬁed as an anti-apoptotic protein
(Nagano-Ito and Ichikawa, 2012).
Another point of interest is the up-regulation of ANXA5 that was
found in 5 nm AuNPs treated cells. ANXA5 was proposed to play a
role in the activation of apoptotic cells (Green and Steinmetz, 2002)
and recently Ghislat et al. (2012) proved that ANXA5 stimulates
autophagy and inhibits endocytosis. Consistently with previous
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Fig. 10. Dose-response of the binding of the ECM on immobilized antibodies against
collagen type I. Comparison of the binding of collagen type I, produced by the
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mntreated cells (control) and AuNPs treated Balb/3T3 cells for 72 h, to the spe-
iﬁc  antibodies. Data are normalized to the control, and reported as mean of three
ndependent experiments ± standard error of the mean.
tudies (Ma  et al., 2011), in this work we showed TEM images of
uNPs found clustered in double-membrane vesicles in the cyto-
lasm, which are typical features of autophagosomes (Figs. 6 and 7).
n light of this observation, we performed 2D-WB for the micro-
ubules associated light chain 3-isoform B (LC3B), a well-known
arker of autophagy. Data shows indeed that LC3B is expressed
nly in AuNPs treated cells and not present in unexposed cells.
herra et al. (2010) have reported that LC3B dephosphorylation
s associated with enhanced recruitment to autophagosomes. As
t can be seen in the 2D Western blot of LC3B, of the two sig-
als, present in the treated sample, the higher intensity of the
pot toward the acidic region is indication of dephosphorylation.
hile the link between oxidative stress leading to autophagy is
uite established (Chen et al., 2011), at present only few works
ave demonstrated that AuNPs could cause authophagy (Ma  et al.,
011). Our ﬁndings support the hypothesis that, while AuNPs
nduce oxidative stress, cells might activate the autophagic path-
ays as a survival mechanism to avoid cell death, as proposed by
i et al. (2010). However, if the intensity or duration of the cel-
ular stress is increased, it converges on cell death (Deegan et al.,
013).
.2. Cell morphology, cell metabolism, cell cycle, cell growth,
ellular functions and maintenance
As remarked by the IPA functional analysis, the rest of the differ-
ntially expressed proteins found in response to AuNPs exposure,
re mainly involved as cell cycle regulators, in cell metabolism and
rowth, or in the cell morphology.
GSN is a protein involved in actin ﬁlament capping, actin ﬁl-
ment polymerization as well as vesicle-mediated transport, and
as found down-regulated mainly in 15 nm AuNPs treated cells.
UBB5, that is a structural constituent of the cytoskeleton, VCL and
UP, two proteins involved in cell adhesion, were found also all
own-regulated in both 5 and 15 nm AuNPs exposed cells. CCT5
hat plays a role, in vitro, in the folding of actin and tubulin was
lso found down-regulated in response to AuNPs treatment. The
bove results could explain the alteration of the cell cytoskeleton
hat occurs following exposure to AuNPs, as previously reported
Coradeghini et al., 2013; Pernodet et al., 2006).
Several proteins involved in cell metabolism were also found
odiﬁed by AuNPs exposure in Balb/3T3 cells. PLIN3 is a proteiners 228 (2014) 111–126
localized in the cytoplasm as well as in the endosome mem-
brane and it is required for the transport of mannose 6-phosphate
receptors from endosomes to the trans-golgi network. Our data
revealed that PLIN3 is up-regulated by exposure to both AuNPs
sizes.
Two isoforms of ACO2, involved in the tricarboxylic acid cycle,
were found down-regulated in response to 5 nm AuNPs, while for
15 nm AuNPs one isoform was  found down-regulated, and the
second isoform was  up-regulated. Presumably, AuNPs treatment
affects carbohydrate metabolism at mitochondria level and this
effect is size dependent.
The glycolytic pathway was also affected by AuNPs–cell inter-
action. Here we report that Pkm was  found down-regulated
after exposure to 5 nm AuNPs, and not to 15 nm AuNPs. ENO1
was instead found down-regulated after exposure to both AuNPs
sizes.
Several proteins involved in amino-acid and protein biosyn-
thesis were found down-regulated in AuNPs exposed cells (TUFM,
EEF1D, PCBP1, PSAT1, UAP1L1, CCT5, GOT2 and EEF2, the latter only
in 5 nm and not in 15 nm AuNPs treated cells). This can explain
the lower number of proteins spot detected in the AuNPs treated
cells compared to the control (Fig. 2D). Furthermore, TEM images
of AuNPs treated cells (Figs. 6 and 7) showing the presence of free
ribosomes, and not membrane-bound to the rough endoplasmatic
reticulum (ER), are another indication that AuNPs have an effect on
protein biosynthesis.
In addition, several proteins associated with cell cycle and
growth regulation were also affected by AuNPs (PPP2R1A, TKT,
SEPT8).
Not much is known about the ubiquitin carboxyl-terminal
hydrolase 5 (USP5), which was  found down regulated only in
15 nm AuNPs-treated cells. Li et al. (2010) have reported ubiquitin
carboxyl-terminal hydrolase isozyme L1 (UCH-L1) as de-regulated
in MRC-5 lung ﬁbroblast when exposed to 20 nm AuNPs for
72 h. At this regard, Hurst-Kennedy et al. (2012) have suggested
a potential tumor suppressor role for UCH-L1. Glutathione S-
transferase (GSTM1), a detoxiﬁcant enzyme that catalyzes the
conjunction of various hydrophilic and electrophilic compounds
with glutathione, was found up-regulated in Au 15 nm exposed-
cells, while down-regulated by less than 2-folds in 5 nm AuNPs
treated cells. The up-regulation of GST has also been reported
in MRC-5 cells exposed to 20 nm AuNPs for 72 h (Li et al.,
2010).
In our analysis, we highlighted that most of the identiﬁed de-
regulated proteins are directly connected to ubiquitin, suggesting
a putative role of ubiquitination as mediator factor between the
different processes disturbed by AuNP treatment.
4.3. Extracellular matrix dysregulation
Miranova et al. (2010) reported a 40% reduction of collagen type
I production in primary human dermal ﬁbroblast when exposed to
13 nm AuNPs for 3 days, while Richter et al. (2011) showed no or
limited measurable effect on collagen production by human pri-
mary ﬁbroblast cells over a 24 h exposure to 20 nm AuNPs. Our
proteomic analysis revealed that COL1A1, an extracellular matrix
structural constituent involved in the collagen ﬁbril organization,
was up-regulated in 15 nm AuNPs treated cells, but less than 2-fold
up-regulated in response to 5 nm AuNPs. On the contrary, SER-
PINH1, involved in the collagen biosynthesis, was instead strongly
down-regulated by the smaller size AuNPs, and not by the 15 nm
AuNPs.To quantify the effects of these deregulated proteins on extracel-
lular matrix (ECM) production, by SPR analysis we demonstrated
that AuNPs treatment triggers the production of Collagen type 1
and ﬁbronectin in Balb/3T3 cells.
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.4. Investigation of other speciﬁc proteins by 2D-Western
lotting
We  conﬁrmed that modiﬁcation of clathrin expression includ-
ng cleavage and changes in the phosphorylation state occurs when
ells are exposed to AuNPs, in accordance with our previous ﬁnd-
ngs (Coradeghini et al., 2013). It is plausible that clathrin is involved
n AuNPs intracellular trafﬁcking. Even if further investigation
eeds to be performed to deﬁne the precise function of clathrin
n the cellular response to AuNPs, the fact that TEM images do not
eveal the presence of clathrin vesicles at cellular membrane level,
ead us also to suggest that clathrin may  play a role in the autophagy
rocess. This has already been observed by Ravikumar et al. (2010)
nd Uttenweiler-Joseph et al. (2013), who reported that clathrin
eavy chain (CLH1) can be implicated in the autophagy process, due
o its involvement in the formation of some early autophagosome
recursors.
We also investigated by 2D-WB the expression proﬁle of cave-
lin and sorting nexin-5 (SNX5), other proteins possibly implicated
n the uptake and internalization processes of AuNPs. By two-
imensional immunoblotting we show that caveolin expression
s slightly modiﬁed by exposure to AuNPs, data that was dif-
cult to reveal by monodimensional blot (Coradeghini et al.,
013).
In the case of SNX5, well-known for its role in the regulation
f macropinocytosis, our data show that different isoforms of the
roteins are expressed in the presence of 5 nm AuNPs. We  can thus
ssume that, as one of the mechanisms of NPs uptake, 5 nm AuNPs
ould be seen by cells as clusters and internalized by macropinocy-
osis.
.5. TEM analysis
Transmission electron microscopy (TEM) study revealed that
fter 72 h exposure, AuNPs were internalized by Balb/3T3 cells and
ainly conﬁned in dense vacuoles. TEM images clearly show the
ough endoplasmic reticule (ER) greatly dilated, and visible-free
ibosomes, thus conﬁrming that prolonged AuNPs treatment (72 h)
nduces endoplasmic reticulum stress, as already described in lit-
rature (Christen et al., 2012).
Reticulum stress damage is one of the best-known inducer of
utophagy (Ryter et al., 2013). In response to stress condition, the
utophagy machinery is activated to help the cell to deal with the
tress conditions so to maintain basic cellular homeostasis. How-
ver, if the intensity or duration of cellular stress is increased, it
onverges on cell death (Deegan et al., 2013).
A connection exists also between mitochondria and autophagy.
itochondria regulate autophagy as a complex pro-survival
esponse that is activated by several stress conditions (Deegan et al.,
013). It is known that mitochondria, together with the ER, may
onstitute the most prominent source of lipids for the biogene-
is of autophagosomes (Hailey et al., 2010). Gomes et al. (2011)
emonstrated that, in response to starvation or other triggers of
utophagy (e.g. rapamycin), mitochondria elongate and escape
rom autophagic degradation so to preserve cell viability. Mito-
hondria elongation to preserve cell viability during the autophagic
esponse has been shown in vitro, in multiple human and murine
ell types as well as in vivo (Galluzzi et al., 2011).
Our observations lead us to the hypothesis that mitochondria
longation is also critical for the survival of cells undergoing AuNPs
tress-induced autophagy. Mitochondria not containing AuNPs get
tretched and elongated in order to resist to the autophagy dam-
ge, whereas when containing AuNPs mitochondria get of round
hape and undergo damage more rapidly. In our opinion mitochon-
ria shape is therefore an indication of possible cytotoxic damage
aused by nanoparticles.ers 228 (2014) 111–126 125
5. Conclusions
The aim of this study was  to broader the actual knowledge on the
changes occurring at protein level in cells when exposed to AuNPs.
In order to understand how AuNPs affect cell biology, which knowl-
edge is still far from being complete, we mapped the cytoplasmic
proteome and investigated the differentially expressed proteins in
Balb/3T3 cells.
The novelty of this work lies in the development of an integrated
approach using complementary techniques applied in the ﬁeld
of nanotoxicology. The combination of 2D-PAGE, high-resolution
mass spectrometry, Western blotting and SPR allowed the speciﬁc
detection and identiﬁcation of several proteins which expression
is altered by AuNPs exposure.
Systems biology analysis was employed to analyze the pro-
teomic data for exploring the AuNPs-elicited cellular mechanism.
Proteins that were differentially expressed were found to cover
a range of functions including cellular growth and proliferation,
cell morphology, cell cycle regulation, cellular function and main-
tenance, oxidative stress, inﬂammatory response and cell death.
The outcome of this work provides a deeper insight into how
AuNPs interact with biological systems. Remarkably, depending
on the nanoparticle size, different biological mechanisms could be
identiﬁed.
By exploring the cellular pathways this paper aims there-
fore to improve exiting knowledge, necessary for assess AuNPs
potential adverse effects or for enhancing their clinical efﬁcacy.
The actual balance between detrimental and beneﬁcial effects is
the critical parameter to consider for AuNPs applications e.g. in
nanomedicine. Future perspectives include the application of the
proteomic approach described in this work to human cell lines that
mimic  exposure routes (e.g. the intestinal barrier or the pulmonary
system).
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